Exact Sciences Corp (EXAS) Posts Q2 Loss of 24c/Share

Exact Sciences Corp (NASDAQ: EXAS) reported Q2 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Exact Sciences Corp (EXAS) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Arrive AI and DXC Technology partner to bring delivery tech to factories
• Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade